Marion Mc Court Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Marion Mc Court is EVP Commercial of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,989 shares of REGN, which is worth approximately $11.6 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 274 shares (Common Stock) at a price of $787.0 per share, resulting in proceeds of $215,638. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K

15.92% 3M change

2.26% 12M change

Total Value Held $11.6 Million

Marion McCourt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2024	SELL Payment of exercise price or tax liability	$215,638 $787.0 p/Share	274 Reduced 1.8%	14,989 Common Stock
Dec 06 2024	BUY Grant, award, or other acquisition	-	2,332 Added 13.25%	15,263 Common Stock
Nov 01 2024	SELL Open market or private sale	$844,610 $844.61 p/Share	1,000 Reduced 7.18%	12,931 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$381,400 $381.4 p/Share	1,000 Added 6.7%	13,931 Common Stock
Oct 01 2024	SELL Open market or private sale	$1,054,060 $1054.06 p/Share	1,000 Reduced 7.18%	12,931 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$381,400 $381.4 p/Share	1,000 Added 6.7%	13,931 Common Stock
Sep 03 2024	SELL Open market or private sale	$1,178,730 $1178.73 p/Share	1,000 Reduced 7.18%	12,931 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$381,400 $381.4 p/Share	1,000 Added 6.7%	13,931 Common Stock
Aug 01 2024	SELL Open market or private sale	$1,206,197 $1060.86 p/Share	1,137 Reduced 8.08%	12,931 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$423,487 $372.46 p/Share	1,137 Added 7.48%	14,068 Common Stock
Jul 01 2024	SELL Open market or private sale	$1,190,564 $1047.11 p/Share	1,137 Reduced 8.08%	12,931 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$423,487 $372.46 p/Share	1,137 Added 7.48%	14,068 Common Stock
Jun 03 2024	SELL Open market or private sale	$1,115,422 $980.16 p/Share	1,138 Reduced 8.09%	12,931 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$423,859 $372.46 p/Share	1,138 Added 7.48%	14,069 Common Stock
May 01 2024	SELL Open market or private sale	$222,352 $889.41 p/Share	250 Reduced 1.9%	12,931 Common Stock
Apr 01 2024	SELL Open market or private sale	$241,182 $964.73 p/Share	250 Reduced 1.86%	13,181 Common Stock
Mar 01 2024	SELL Open market or private sale	$346,365 $967.5 p/Share	358 Reduced 2.6%	13,431 Common Stock
Feb 05 2024	SELL Open market or private sale	$934,710 $934.71 p/Share	1,000 Reduced 6.76%	13,789 Common Stock
Feb 01 2024	SELL Open market or private sale	$258,151 $945.61 p/Share	273 Reduced 1.81%	14,789 Common Stock
Jan 02 2024	SELL Open market or private sale	$239,451 $873.91 p/Share	274 Reduced 1.79%	15,062 Common Stock
Dec 12 2023	SELL Payment of exercise price or tax liability	$4,373,504 $856.71 p/Share	5,105 Reduced 24.97%	15,336 Common Stock
Dec 11 2023	SELL Payment of exercise price or tax liability	$314,845 $844.09 p/Share	373 Reduced 1.79%	20,441 Common Stock
Dec 11 2023	SELL Open market or private sale	$226,378 $838.44 p/Share	270 Reduced 1.28%	20,814 Common Stock
Dec 08 2023	SELL Payment of exercise price or tax liability	$718,909 $843.79 p/Share	852 Reduced 4.3%	18,951 Common Stock
Dec 08 2023	BUY Grant, award, or other acquisition	-	2,133 Added 9.19%	21,084 Common Stock

Marion Mc Court

EVP Commercial

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account